SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction?

por Olcese, C., Casciaro, R., Pirlo, D., Debbia, C., Castagnola, E., Cresta, F., Castellani, C.
Publicado 2021

COVID-19 vaccine prioritisation for people with cystic fibrosis

por Carr, Siobhán B, Cosgriff, Rebecca, Harutyunyan, Satenik, Middleton, Peter G, Ruseckaite, Rasa, Ahern, Susannah, Daneau, Géraldine, Filho, Luiz Vicente R F da Silva, Stephenson, Anne L, Cheng, Stephanie Y, Melo, Joel, Corvol, Harriet, Burgel, Pierre-Régis, Nährlich, Lutz, McKone, Edward, Colombo, Carla, Salvatore, Marco, Padoan, Rita, Abdrakhmanov, Olzhas, Gulmans, Vincent, Byrnes, Catherine A, Amelina, Elena, Kondratyeva, Elena, Zhekayte, Elena, Kashirskaya, Nataliya, Zampoli, Marco, Pastor-Vivero, M Dolores, Mondejar-Lopez, Pedro, de Monestrol, Isabelle, Jung, Andeas, McClenaghan, Elliot, Brownlee, Keith, Rizvi, Samar, Goss, Christopher H, Elbert, Alexander, Faro, Albert, Gutierrez, Hector, Marshall, Bruce C
Publicado 2021

The virtual CF clinic: Implications for sputum microbiology

por Moore, John E., Millar, B. Cherie, McCaughan, John, O'Neill, Damian, Bell, Jane, Crossan, Amanda, Rendall, Jacqueline C.
Publicado 2021

A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis

por Paynter, Alex, Khan, Umer, Heltshe, Sonya L., Goss, Christopher H., Lechtzin, Noah, Hamblett, Nicole Mayer
Publicado 2022

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy

por Alicandro, Gianfranco, Daccó, Valeria, Cariani, Lisa, Contarini, Martina, Morlacchi, Letizia Corinna, Rosazza, Chiara, Sciarrabba, Calogero Sathya, Ferraro, Federica, Orena, Beatrice Silvia, Gramegna, Andrea, Blasi, Francesco, Colombo, Carla
Publicado 2022

Speaking of pandemics...

por Schechter, Michael S.
Publicado 2021

Regarding the articles on home spirometry

por Curley, Rachael, Campbell, Michael J, Walters, Stephen J, Hoo, Zhe Hui, Wildman, Martin J
Publicado 2022

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over

por Alicandro, Gianfranco, Daccó, Valeria, Cariani, Lisa, Contarini, Martina, Morlacchi, Letizia Corinna, Rosazza, Chiara, Sciarrabba, Calogero Sathya, Ferraro, Federica, Lanfranchi, Chiara, Orena, Beatrice Silvia, Gramegna, Andrea, Blasi, Francesco, Colombo, Carla
Publicado 2022

The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York()

por Simonson, Joseph L., Esposito, Christine, Frantzen, Theresa, Henthorne, Katherine, Espinal, Aileen, Romano, Serena, Ramdeo, Ramona, Trentacoste, Jessica, Tsang, Donna, LaVecchia, Geralyn, Abdullah, Robert, Berdella, Maria, Bonitz, Lynn, Condos, Rany, Constantinescu, Andrei, DeCelie-Germana, Joan K., DiMango, Emily, Draine, Myah, Gimeli, Tara, Giusti, Robert, Guzman, Jessenia, Hammouda, Soumia, Keating, Claire, Kier, Catherine, Lennox, Alison T., Liriano, Carmen, Messer, Zachary, Plachta, Amy, Sadeghi, Hossein, Schwind, Elinor, Stables-Carney, Teresa, Walker, Patricia, Wang, Janice
Publicado 2022

A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021

por Barr, H.L., Bihouee, T., Zwitserloot, A.M.
Publicado 2022

Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis

por Michos, Athanasios, Filippatos, Filippos, Tatsi, Elizabeth-Barbara, Dellis, Charilaos, Efthymiou, Vasiliki, Zarkada, Ioanna, Troupi, Evgenia, Syriopoulou, Vasiliki, Loukou, Ioanna
Publicado 2022

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

por Carr, Siobhán B, McClenaghan, Elliot, Elbert, Alexander, Faro, Albert, Cosgriff, Rebecca, Abdrakhmanov, Olzhas, Brownlee, Keith, Burgel, Pierre-Régis, Byrnes, Catherine A, Cheng, Stephanie Y, Colombo, Carla, Corvol, Harriet, Daneau, Géraldine, Goss, Christopher H, Gulmans, Vincent, Gutierrez, Hector, Harutyunyan, Satenik, Helmick, Meagan, Jung, Andreas, Kashirskaya, Nataliya, McKone, Edward, Melo, Joel, Middleton, Peter G, Mondejar-Lopez, Pedro, de Monestrol, Isabelle, Nährlich, Lutz, Padoan, Rita, Parker, Megan, Pastor-Vivero, M Dolores, Rizvi, Samar, Ruseckaite, Rasa, Salvatore, Marco, da Silva-Filho, Luiz Vicente R F, Versmessen, Nick, Zampoli, Marco, Marshall, Bruce C, Stephenson, Anne L
Publicado 2022

A year in review (2022): Modulators and COVID19, the story goes on…

por Dillenhoefer, Stefanie, Grogono, Dorothy, Morales-Tirado, Ana
Publicado 2023

The impact of telehealth based care on paediatric cystic fibrosis outcomes

por Rimbaldo, Kristene, Frayman, Katherine B, Shanthikumar, Shivanthan
Publicado 2023

Healthcare reassessment in a pandemics time: challenges for CF

por Castellani, Carlo
Publicado 2020

New therapies for people with CF in the CFTR modulator world

por Wainwright, Claire E
Publicado 2020

Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19

por McElvaney, Oliver J, O'Connor, Eoin, McEvoy, Natalie L, Fraughan, Daniel D, Clarke, Jennifer, McElvaney, Oisín F, Gunaratnam, Cedric, O'Rourke, James, Curley, Gerard F, McElvaney, Noel G
Publicado 2021

Evaluating barriers to and promotors of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs (Commentary)()

por Ranganathan, Sarath C.
Publicado 2021

Telehealth after the pandemic: Will the inverse care law apply? (Commentary)()

por Calthorpe, Rebecca J, Smyth, Alan R.
Publicado 2021

TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)()

por Franciosi, Alessandro N, Quon, Bradley S
Publicado 2021